Opeyemi Olabisi Duke UniversityUnited States

Dr. Olabisi is a physician scientist whose research focuses on APOL1-mediated kidney disease (AMKD). He leverages cell-based models, human stem cell-derived models, and transgenic APOL1 animal model to elucidate the mechanism underlying AMKD. He also conducts NIH-funded community-engaged translational and clinical research (learn more here, www.kidneycareandjustice.com) with the goal of developing innovative cure and prevention of AMKD.

1 APRIL 2023

Time	Session

08:30 10:00	APOL1 and Kidney Failure Chiao Yuen Lim Chairperson Brunei Ifeoma Ulasi Chairperson University of Nigeria Teaching HospitalNigeria H3Africa, Kidney Failure, and APOL1 Dr Akinlolu Ojo Speaker ojo@kumc.eduUniversity of Kansas School of MedicineUnited States COVID, APOL1, and Mechanisms of Kidney Failure Opeyemi Olabisi Speaker Duke UniversityUnited States APOL1 and the Donor-Recipient Risk Profile Barry Freedman Speaker Wake Forest University School of Medicine United States Sharing APOL1 Genetic Data with Clinicians and Researchers Bessie Young Speaker University of WashingtonUnited States Q and A Ballroom 1
17:00 18:00	*This session is for In-Person delegates only Poster session 2 Acid-base and Electrolyte Abnormalities in Kidney Disease Andréa Stinghen Moderator Universidade Federal do ParanáBrazil Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2 Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3 Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand Chronic Kidney Disease Diagnosis, Classification and Progression 2 Richard Kitching Moderator Monash University, Monash Medical CenterAustralia Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2 Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States Clinical Glomerulonephritis 3 Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina Covid-19 and CKD Opeyemi Olabisi Moderator Duke UniversityUnited States Curriculum Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com Diabetic Kidney Disease, Drugs and Treatments 2 Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2 Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon Epidemiology, Outcomes and Health Services Research in Dialysis 2 Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil Essential Hypertension and Renovascular Kidney Disease Barry Freedman Moderator Wake Forest University School of Medicine United States Genetics and Epigenetics (Including Common and Rare Genetic Diseases) Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand Haemodialysis, Haemodiafiltration and Vascular Access 2 Brendan Smyth Moderator St George HospitalAustralia Haemodialysis, Haemodiafiltration and Vascular Access 3 Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States Inflammation, Fibrosis, Matrix Biology and Oxidative Stress Youhua LIU Moderator University of PittsburghUnited States Kidney Transplantation and Transplant Immunology 3 Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia Kidney Transplantation and Transplant Immunology 4 Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com Late Breaking Clinical Trials Muh Geot Wong Moderator University of SydneyAustralia Nephrotic Syndrome Alessia Fornoni Moderator University of MiamiUnited States Other CKD 2 Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina Other KF (Kidney Failure) Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan Peritoneal Dialysis 2 Piyatida Chuengsaman Moderator Thailand Peritoneal Dialysis 3 Afiatin Abdurahman Moderator Training Naowanit Nata Moderator Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms) Opas Traitanon Moderator Urologic Disorders Sritippayawan Suchai Moderator Siriraj Hospital Thailand Vascular Biology and Endothelial Function Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan Ballroom 2-3-4-Exhibition Hall